Rhoh deficiency reduces peripheral T-cell function and attenuates allogenic transplant rejection
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Rhoh deficiency reduces peripheral T-cell function and attenuates allogenic transplant rejection. / Porubsky, Stefan; Wang, Shijun; Kiss, Eva; Dehmel, Stefan; Bonrouhi, Mahnaz; Dorn, Tatjana; Luckow, Bruno; Brakebusch, Cord; Gröne, Hermann-Josef.
I: European Journal of Immunology, Bind 41, Nr. 1, 01.01.2011, s. 76-88.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Rhoh deficiency reduces peripheral T-cell function and attenuates allogenic transplant rejection
AU - Porubsky, Stefan
AU - Wang, Shijun
AU - Kiss, Eva
AU - Dehmel, Stefan
AU - Bonrouhi, Mahnaz
AU - Dorn, Tatjana
AU - Luckow, Bruno
AU - Brakebusch, Cord
AU - Gröne, Hermann-Josef
N1 - Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2011/1/1
Y1 - 2011/1/1
N2 - Rhoh is a hematopoietic system-specific GTPase. Rhoh-deficient T cells have been shown to have a defect in TCR signaling manifested during their thymic development. Our aims were to investigate the phenotype of peripheral Rhoh-deficient T cells and to explore in vivo the potential benefit of Rhoh deficiency in a clinically relevant situation, in which T-cell inhibition is desirable. In murine allogenic kidney transplantation, Rhoh deficiency caused a significant 75% reduction of acute and chronic transplant rejection accompanied by 75% lower alloantigen-specific antibody levels and significantly better graft function. This effect was independent of the lower T-cell numbers in Rhoh-deficient recipients, because injection of equal numbers of Rhoh-deficient or control T cells into kidney transplanted mice with SCID led again to a significant 60% reduction of rejection. Mixed lymphocyte reaction revealed that the weaker alloreactivity was associated with a 85% lower cytotoxicity and a 50-80% lower cytokine release in Rhoh-deficient T cells without an influence on the secretion itself. Antigen uptake and presentation in DC were unaffected by Rhoh deficiency. These findings stress the importance of Rhoh for the function of peripheral T cells.
AB - Rhoh is a hematopoietic system-specific GTPase. Rhoh-deficient T cells have been shown to have a defect in TCR signaling manifested during their thymic development. Our aims were to investigate the phenotype of peripheral Rhoh-deficient T cells and to explore in vivo the potential benefit of Rhoh deficiency in a clinically relevant situation, in which T-cell inhibition is desirable. In murine allogenic kidney transplantation, Rhoh deficiency caused a significant 75% reduction of acute and chronic transplant rejection accompanied by 75% lower alloantigen-specific antibody levels and significantly better graft function. This effect was independent of the lower T-cell numbers in Rhoh-deficient recipients, because injection of equal numbers of Rhoh-deficient or control T cells into kidney transplanted mice with SCID led again to a significant 60% reduction of rejection. Mixed lymphocyte reaction revealed that the weaker alloreactivity was associated with a 85% lower cytotoxicity and a 50-80% lower cytokine release in Rhoh-deficient T cells without an influence on the secretion itself. Antigen uptake and presentation in DC were unaffected by Rhoh deficiency. These findings stress the importance of Rhoh for the function of peripheral T cells.
KW - Acute Disease
KW - Animals
KW - Antibodies
KW - Antigen Presentation
KW - Chronic Disease
KW - Cytokines
KW - Dendritic Cells
KW - Graft Rejection
KW - Isoantigens
KW - Kidney Transplantation
KW - Lymphocyte Culture Test, Mixed
KW - Male
KW - Mice
KW - Mice, Inbred BALB C
KW - Mice, Mutant Strains
KW - Mice, SCID
KW - T-Lymphocytes
KW - Transcription Factors
KW - rho GTP-Binding Proteins
U2 - 10.1002/eji.201040420
DO - 10.1002/eji.201040420
M3 - Journal article
C2 - 21182079
VL - 41
SP - 76
EP - 88
JO - European Journal of Immunology
JF - European Journal of Immunology
SN - 0014-2980
IS - 1
ER -
ID: 33902024